STOCK TITAN

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) will hold a conference call at 8:30 a.m. Eastern Time on October 18, 2022, to discuss its third-quarter results. The call features Joseph J. Wolk, CFO, and Jessica Moore, VP of Investor Relations, along with other executives. Interested parties can join via webcast or telephone, with details available on the company's investor relations website. A replay will be accessible until November 1, 2022. The press release will be published at 6:45 a.m. Eastern Time on the same day.

Positive
  • None.
Negative
  • None.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, 2022, to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson’s executive team.

Investors and other interested parties can access the webcast/conference call in the following ways:

  • The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
  • By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
  • A replay of the conference call will be available until approximately 12:00 a.m. on November 1st. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13732673.
  • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
  • Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the fourth-quarter date of Tuesday, January 24th, 2023.

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Press Contact:

Jake Sargent

(732) 524-1090

Investor Contacts:

Jessica Moore

(732) 524-2955

Sarah Wood

(732) 524-2617

Source: Johnson & Johnson

FAQ

When is Johnson & Johnson's Q3 conference call in 2022?

Johnson & Johnson's Q3 conference call is scheduled for 8:30 a.m. Eastern Time on October 18, 2022.

How can I access the Johnson & Johnson conference call?

You can access the Johnson & Johnson conference call via webcast on their investor relations website or by telephone at 877-869-3847 for U.S. participants.

Is there a replay available for the Johnson & Johnson conference call?

Yes, a replay of the conference call will be available until 12:00 a.m. on November 1, 2022.

What time will the press release be available for Johnson & Johnson's conference call?

The press release will be available at 6:45 a.m. Eastern Time on the day of the conference call.

Who will host the Johnson & Johnson conference call?

The conference call will be hosted by CFO Joseph J. Wolk and VP of Investor Relations Jessica Moore, along with other executives.

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

349.23B
2.41B
0.09%
73.13%
0.77%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW BRUNSWICK